Author: Cillian Osterfield - Page 3

Anorexia and bulimia are life-threatening mental illnesses with proven treatments. Learn what actually works-Family-Based Treatment, CBT-E, and the barriers keeping people from care.

Tirzepatide (Zepbound) is a dual GLP-1 and GIP agonist that helps with weight loss by targeting appetite, fat storage, and metabolism. It leads to up to 22.4% body weight loss in trials and outperforms older drugs like semaglutide.

Combining warfarin and NSAIDs can more than quadruple your risk of serious bleeding. Learn why this interaction is dangerous, which painkillers are safest, and what to do if you need pain relief while on blood thinners.

Learn how to read refill information on your prescription label to avoid running out of medication. Understand what 'Ref: 3' means, when to request refills, and how to use digital tools to stay on track.

Learn how to prevent and treat low blood sugar caused by diabetes medications like insulin and sulfonylureas. This practical guide covers risk factors, emergency treatment, tracking patterns, and new technologies to stay safe.

Giardia and pinworms are common parasitic infections that cause diarrhea and intense itching, respectively. Learn how they spread, how to diagnose them, and what treatments actually work-plus how to prevent reinfection.

Uremic symptoms like nausea and itching signal dangerous toxin buildup in kidney failure. Learn when to start dialysis based on symptoms-not just lab numbers-and how new treatments can restore your quality of life.

Obesity doesn't just mean extra weight-it triggers diabetes, heart disease, and sleep apnea in a dangerous cycle. Learn how these conditions connect, why treating one helps the others, and what actually works to break the pattern.

Stimulants for ADHD can improve focus but carry a small risk of cardiac arrhythmias. Learn who's at risk, how doctors assess heart health, and what non-stimulant alternatives work when safety comes first.

In 2025, the U.S. government is responding to record drug shortages with stockpiling, AI monitoring, and new laws-but critical gaps remain in manufacturing, enforcement, and economic incentives that keep shortages alive.